Latest news
Socrodeucitinib Meets Primary Endpoint in Phase 2 Psoriasis Study - HCPLiveHCPLive · Fri, 07 Aug 2026 23:10:36 GMTOral TYK2 Inhibitor Socrodeucitinib Meets Primary Endpoint in Phase 2 Psoriasis Trial - Dermatology TimesDermatology Times · Fri, 07 Aug 2026 16:04:43 GMTNamilumab Fails to Meet Primary End Point in Pulmonary Sarcoidosis - HCPLiveHCPLive · Fri, 07 Aug 2026 14:06:13 GMTBemnifosbuvir/Ruzasvir Meets Primary Endpoint in Phase 3 HCV Trial - Contagion LiveContagion Live · Mon, 03 Aug 2026 12:06:41 GMTNovo Nordisk fails to meet primary endpoint in phase 3 trial - marketscreener.commarketscreener.com · Fri, 31 Jul 2026 07:00:00 GMTRitlecitinib Meets Co-Primary End Points in Phase 3 Nonsegmental Vitiligo Trials - Dermatology TimesDermatology Times · Thu, 30 Jul 2026 13:32:39 GMTHansoh Pharma says osteosarcoma treatment drug meets primary endpoint in late stage trial - 101 WIXX101 WIXX · Tue, 28 Jul 2026 11:46:48 GMTGSK's Bone Cancer Drug Meets Primary Endpoint in Late-stage China Study - MoomooMoomoo · Tue, 28 Jul 2026 07:00:00 GMT